In experimental settings, it is investigated for its relationship to telomere biology, oxidative stress response, neuroprotective pathways, and broader longevity-focused cellular models
FDA crackdown on compounding pharmacies (2023-2024) What happened: FDA increased scrutiny of compounded semaglutide Concerns about shortages vs compounding exemptions Some compounding pharmacies received warning letters Impact: Harder to get compounded versions of FDA-approved drugs Some clinics stopped offering certain peptides Shifted more toward truly non-approved peptides Takeaway: Regulatory environment tightening around compounded versions of FDA-approved drugs
Like most things, the answer isnt cut-and-dry, but lets break it down together to understand what factors influence this timeline and what else these powerful shots can do for you
Targeting uric acid prevents brain injury and anxiety in a rat model of hemorrhagic
GLP-1R agonists have demonstrated the ability to improve cognitive function, reduce hippocampal synaptic loss, and decrease A plaque deposition and A oligomer levels in APP/PS1 transgenic mice [53, 54]
